nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Methoxsalen—hematologic cancer	0.0823	0.134	CbGbCtD
Letrozole—CYP19A1—Betamethasone—hematologic cancer	0.064	0.104	CbGbCtD
Letrozole—CYP2A6—Ifosfamide—hematologic cancer	0.06	0.0975	CbGbCtD
Letrozole—CYP2A6—Prednisolone—hematologic cancer	0.04	0.065	CbGbCtD
Letrozole—CYP19A1—Dexamethasone—hematologic cancer	0.0372	0.0605	CbGbCtD
Letrozole—CYP3A4—Bexarotene—hematologic cancer	0.0255	0.0415	CbGbCtD
Letrozole—CYP3A4—Busulfan—hematologic cancer	0.0237	0.0386	CbGbCtD
Letrozole—CYP3A4—Lomustine—hematologic cancer	0.0237	0.0386	CbGbCtD
Letrozole—CYP2A6—Dexamethasone—hematologic cancer	0.0236	0.0383	CbGbCtD
Letrozole—CYP3A4—Thiotepa—hematologic cancer	0.0211	0.0344	CbGbCtD
Letrozole—CYP19A1—ovarian follicle—hematologic cancer	0.0187	0.628	CbGeAlD
Letrozole—CYP3A4—Methoxsalen—hematologic cancer	0.0164	0.0267	CbGbCtD
Letrozole—CYP3A4—Bortezomib—hematologic cancer	0.0156	0.0254	CbGbCtD
Letrozole—CYP3A4—Daunorubicin—hematologic cancer	0.015	0.0243	CbGbCtD
Letrozole—CYP3A4—Cytarabine—hematologic cancer	0.0132	0.0215	CbGbCtD
Letrozole—CYP3A4—Teniposide—hematologic cancer	0.013	0.0211	CbGbCtD
Letrozole—CYP3A4—Ifosfamide—hematologic cancer	0.012	0.0195	CbGbCtD
Letrozole—CYP3A4—Imatinib—hematologic cancer	0.0115	0.0186	CbGbCtD
Letrozole—CYP3A4—Ruxolitinib—hematologic cancer	0.0108	0.0175	CbGbCtD
Letrozole—CYP3A4—Nilotinib—hematologic cancer	0.0104	0.0169	CbGbCtD
Letrozole—CYP3A4—Vinorelbine—hematologic cancer	0.0103	0.0168	CbGbCtD
Letrozole—CYP3A4—Triamcinolone—hematologic cancer	0.00945	0.0154	CbGbCtD
Letrozole—CYP3A4—Dasatinib—hematologic cancer	0.00921	0.015	CbGbCtD
Letrozole—CYP3A4—Mitoxantrone—hematologic cancer	0.00909	0.0148	CbGbCtD
Letrozole—CYP3A4—Betamethasone—hematologic cancer	0.0081	0.0132	CbGbCtD
Letrozole—CYP3A4—Prednisolone—hematologic cancer	0.008	0.013	CbGbCtD
Letrozole—CYP3A4—Prednisone—hematologic cancer	0.00755	0.0123	CbGbCtD
Letrozole—CYP3A4—Irinotecan—hematologic cancer	0.00716	0.0116	CbGbCtD
Letrozole—CYP3A4—Vinblastine—hematologic cancer	0.00637	0.0103	CbGbCtD
Letrozole—CYP3A4—Vincristine—hematologic cancer	0.00626	0.0102	CbGbCtD
Letrozole—CYP3A4—Etoposide—hematologic cancer	0.00573	0.00932	CbGbCtD
Letrozole—CYP3A4—Dexamethasone—hematologic cancer	0.00471	0.00766	CbGbCtD
Letrozole—CYP3A4—Doxorubicin—hematologic cancer	0.00391	0.00636	CbGbCtD
Letrozole—CYP19A1—hematopoietic system—hematologic cancer	0.00226	0.0758	CbGeAlD
Letrozole—CYP19A1—gonad—hematologic cancer	0.00172	0.0576	CbGeAlD
Letrozole—CYP2A6—lung—hematologic cancer	0.00167	0.0561	CbGeAlD
Letrozole—CYP19A1—blood—hematologic cancer	0.0015	0.0502	CbGeAlD
Letrozole—CYP19A1—testis—hematologic cancer	0.00124	0.0415	CbGeAlD
Letrozole—CYP3A4—hematopoietic system—hematologic cancer	0.0011	0.0367	CbGeAlD
Letrozole—CYP19A1—lymph node—hematologic cancer	0.000897	0.0301	CbGeAlD
Letrozole—CYP3A4—blood—hematologic cancer	0.000726	0.0243	CbGeAlD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ABL1—hematologic cancer	4.25e-05	0.00327	CbGpPWpGaD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	4.15e-05	0.0032	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—HSP90AA1—hematologic cancer	4e-05	0.00309	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	3.96e-05	0.00305	CbGpPWpGaD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	3.93e-05	0.00303	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTP1—hematologic cancer	3.91e-05	0.00302	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BAX—hematologic cancer	3.89e-05	0.003	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—hematologic cancer	3.89e-05	0.003	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—GSTP1—hematologic cancer	3.86e-05	0.00298	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—JAK1—hematologic cancer	3.81e-05	0.00294	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—hematologic cancer	3.6e-05	0.00277	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTM1—hematologic cancer	3.6e-05	0.00277	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTP1—hematologic cancer	3.55e-05	0.00274	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—GSTM1—hematologic cancer	3.55e-05	0.00273	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	3.54e-05	0.00273	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TSC2—hematologic cancer	3.36e-05	0.00259	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDK2—hematologic cancer	3.33e-05	0.00257	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	3.3e-05	0.00254	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTM1—hematologic cancer	3.26e-05	0.00252	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—HGF—hematologic cancer	3.26e-05	0.00252	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	3.25e-05	0.00251	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ATM—hematologic cancer	3.16e-05	0.00244	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CDK4—hematologic cancer	3.15e-05	0.00243	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—hematologic cancer	3.14e-05	0.00242	CbGpPWpGaD
Letrozole—Decreased appetite—Dexamethasone—hematologic cancer	3.13e-05	9.16e-05	CcSEcCtD
Letrozole—Decreased appetite—Betamethasone—hematologic cancer	3.13e-05	9.16e-05	CcSEcCtD
Letrozole—Nausea—Mitoxantrone—hematologic cancer	3.13e-05	9.15e-05	CcSEcCtD
Letrozole—Nausea—Irinotecan—hematologic cancer	3.13e-05	9.15e-05	CcSEcCtD
Letrozole—Infection—Prednisone—hematologic cancer	3.12e-05	9.12e-05	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—GSTP1—hematologic cancer	3.12e-05	0.0024	CbGpPWpGaD
Letrozole—Mediastinal disorder—Epirubicin—hematologic cancer	3.12e-05	9.11e-05	CcSEcCtD
Letrozole—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.11e-05	9.1e-05	CcSEcCtD
Letrozole—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.11e-05	9.1e-05	CcSEcCtD
Letrozole—Back pain—Methotrexate—hematologic cancer	3.11e-05	9.09e-05	CcSEcCtD
Letrozole—Fatigue—Betamethasone—hematologic cancer	3.11e-05	9.09e-05	CcSEcCtD
Letrozole—Fatigue—Dexamethasone—hematologic cancer	3.11e-05	9.09e-05	CcSEcCtD
Letrozole—Pruritus—Etoposide—hematologic cancer	3.1e-05	9.06e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	3.09e-05	0.00238	CbGpPWpGaD
Letrozole—Pain—Betamethasone—hematologic cancer	3.08e-05	9.01e-05	CcSEcCtD
Letrozole—Pain—Dexamethasone—hematologic cancer	3.08e-05	9.01e-05	CcSEcCtD
Letrozole—Nervous system disorder—Prednisone—hematologic cancer	3.08e-05	9e-05	CcSEcCtD
Letrozole—Tachycardia—Prednisone—hematologic cancer	3.07e-05	8.96e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BAD—hematologic cancer	3.06e-05	0.00236	CbGpPWpGaD
Letrozole—Alopecia—Epirubicin—hematologic cancer	3.05e-05	8.93e-05	CcSEcCtD
Letrozole—Skin disorder—Prednisone—hematologic cancer	3.05e-05	8.92e-05	CcSEcCtD
Letrozole—Nausea—Gemcitabine—hematologic cancer	3.05e-05	8.91e-05	CcSEcCtD
Letrozole—Vomiting—Cisplatin—hematologic cancer	3.04e-05	8.89e-05	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisone—hematologic cancer	3.04e-05	8.87e-05	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—hematologic cancer	3.03e-05	8.86e-05	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—hematologic cancer	3.03e-05	8.85e-05	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—hematologic cancer	3.02e-05	8.84e-05	CcSEcCtD
Letrozole—Rash—Cisplatin—hematologic cancer	3.02e-05	8.82e-05	CcSEcCtD
Letrozole—Dermatitis—Cisplatin—hematologic cancer	3.01e-05	8.81e-05	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—hematologic cancer	3.01e-05	8.8e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—PHYH—hematologic cancer	3e-05	0.00231	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GMPS—hematologic cancer	3e-05	0.00231	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—FTCD—hematologic cancer	3e-05	0.00231	CbGpPWpGaD
Letrozole—Diarrhoea—Etoposide—hematologic cancer	3e-05	8.76e-05	CcSEcCtD
Letrozole—Anorexia—Prednisone—hematologic cancer	2.99e-05	8.75e-05	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—hematologic cancer	2.99e-05	8.74e-05	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—hematologic cancer	2.98e-05	8.72e-05	CcSEcCtD
Letrozole—Feeling abnormal—Dexamethasone—hematologic cancer	2.97e-05	8.69e-05	CcSEcCtD
Letrozole—Feeling abnormal—Betamethasone—hematologic cancer	2.97e-05	8.69e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.97e-05	0.00229	CbGpPWpGaD
Letrozole—Cardiac disorder—Doxorubicin—hematologic cancer	2.97e-05	8.68e-05	CcSEcCtD
Letrozole—Flushing—Doxorubicin—hematologic cancer	2.97e-05	8.68e-05	CcSEcCtD
Letrozole—Tension—Epirubicin—hematologic cancer	2.95e-05	8.63e-05	CcSEcCtD
Letrozole—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.95e-05	8.62e-05	CcSEcCtD
Letrozole—Gastrointestinal pain—Betamethasone—hematologic cancer	2.95e-05	8.62e-05	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—hematologic cancer	2.95e-05	8.61e-05	CcSEcCtD
Letrozole—Nervousness—Epirubicin—hematologic cancer	2.92e-05	8.54e-05	CcSEcCtD
Letrozole—Back pain—Epirubicin—hematologic cancer	2.91e-05	8.51e-05	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—hematologic cancer	2.9e-05	8.48e-05	CcSEcCtD
Letrozole—Malaise—Methotrexate—hematologic cancer	2.9e-05	8.48e-05	CcSEcCtD
Letrozole—Dizziness—Etoposide—hematologic cancer	2.9e-05	8.47e-05	CcSEcCtD
Letrozole—Vertigo—Methotrexate—hematologic cancer	2.89e-05	8.45e-05	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—hematologic cancer	2.88e-05	8.43e-05	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—hematologic cancer	2.88e-05	8.41e-05	CcSEcCtD
Letrozole—Urticaria—Betamethasone—hematologic cancer	2.86e-05	8.37e-05	CcSEcCtD
Letrozole—Urticaria—Dexamethasone—hematologic cancer	2.86e-05	8.37e-05	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—GSTM1—hematologic cancer	2.86e-05	0.00221	CbGpPWpGaD
Letrozole—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.86e-05	8.36e-05	CcSEcCtD
Letrozole—Dizziness—Prednisolone—hematologic cancer	2.86e-05	8.35e-05	CcSEcCtD
Letrozole—Asthenia—Triamcinolone—hematologic cancer	2.85e-05	8.34e-05	CcSEcCtD
Letrozole—Body temperature increased—Dexamethasone—hematologic cancer	2.85e-05	8.33e-05	CcSEcCtD
Letrozole—Abdominal pain—Dexamethasone—hematologic cancer	2.85e-05	8.33e-05	CcSEcCtD
Letrozole—Abdominal pain—Betamethasone—hematologic cancer	2.85e-05	8.33e-05	CcSEcCtD
Letrozole—Body temperature increased—Betamethasone—hematologic cancer	2.85e-05	8.33e-05	CcSEcCtD
Letrozole—Nausea—Cisplatin—hematologic cancer	2.84e-05	8.3e-05	CcSEcCtD
Letrozole—Insomnia—Prednisone—hematologic cancer	2.84e-05	8.3e-05	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—hematologic cancer	2.84e-05	8.29e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.83e-05	0.00218	CbGpPWpGaD
Letrozole—Alopecia—Doxorubicin—hematologic cancer	2.83e-05	8.26e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CREB1—hematologic cancer	2.82e-05	0.00218	CbGpPWpGaD
Letrozole—Paraesthesia—Prednisone—hematologic cancer	2.82e-05	8.24e-05	CcSEcCtD
Letrozole—Pruritus—Triamcinolone—hematologic cancer	2.81e-05	8.22e-05	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—PDGFB—hematologic cancer	2.81e-05	0.00216	CbGpPWpGaD
Letrozole—Cough—Methotrexate—hematologic cancer	2.81e-05	8.2e-05	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—hematologic cancer	2.8e-05	8.19e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.8e-05	0.00216	CbGpPWpGaD
Letrozole—Ill-defined disorder—Epirubicin—hematologic cancer	2.79e-05	8.16e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—hematologic cancer	2.79e-05	0.00215	CbGpPWpGaD
Letrozole—Vomiting—Etoposide—hematologic cancer	2.79e-05	8.14e-05	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—hematologic cancer	2.78e-05	8.14e-05	CcSEcCtD
Letrozole—Dyspepsia—Prednisone—hematologic cancer	2.76e-05	8.08e-05	CcSEcCtD
Letrozole—Rash—Etoposide—hematologic cancer	2.76e-05	8.08e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—hematologic cancer	2.76e-05	0.00213	CbGpPWpGaD
Letrozole—Dermatitis—Etoposide—hematologic cancer	2.76e-05	8.07e-05	CcSEcCtD
Letrozole—Headache—Etoposide—hematologic cancer	2.75e-05	8.02e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—SMPD3—hematologic cancer	2.74e-05	0.00211	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—RB1—hematologic cancer	2.74e-05	0.00211	CbGpPWpGaD
Letrozole—Chest pain—Methotrexate—hematologic cancer	2.74e-05	8e-05	CcSEcCtD
Letrozole—Myalgia—Methotrexate—hematologic cancer	2.74e-05	8e-05	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—hematologic cancer	2.74e-05	8e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.74e-05	0.00211	CbGpPWpGaD
Letrozole—Tension—Doxorubicin—hematologic cancer	2.73e-05	7.99e-05	CcSEcCtD
Letrozole—Decreased appetite—Prednisone—hematologic cancer	2.73e-05	7.98e-05	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—hematologic cancer	2.73e-05	7.97e-05	CcSEcCtD
Letrozole—Rash—Prednisolone—hematologic cancer	2.72e-05	7.97e-05	CcSEcCtD
Letrozole—Dermatitis—Prednisolone—hematologic cancer	2.72e-05	7.96e-05	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.72e-05	7.95e-05	CcSEcCtD
Letrozole—Malaise—Epirubicin—hematologic cancer	2.71e-05	7.93e-05	CcSEcCtD
Letrozole—Fatigue—Prednisone—hematologic cancer	2.71e-05	7.91e-05	CcSEcCtD
Letrozole—Headache—Prednisolone—hematologic cancer	2.71e-05	7.91e-05	CcSEcCtD
Letrozole—Discomfort—Methotrexate—hematologic cancer	2.71e-05	7.91e-05	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—hematologic cancer	2.7e-05	7.91e-05	CcSEcCtD
Letrozole—Vertigo—Epirubicin—hematologic cancer	2.7e-05	7.9e-05	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—hematologic cancer	2.69e-05	7.87e-05	CcSEcCtD
Letrozole—Back pain—Doxorubicin—hematologic cancer	2.69e-05	7.87e-05	CcSEcCtD
Letrozole—Constipation—Prednisone—hematologic cancer	2.69e-05	7.85e-05	CcSEcCtD
Letrozole—Palpitations—Epirubicin—hematologic cancer	2.66e-05	7.77e-05	CcSEcCtD
Letrozole—Dizziness—Triamcinolone—hematologic cancer	2.63e-05	7.68e-05	CcSEcCtD
Letrozole—Cough—Epirubicin—hematologic cancer	2.63e-05	7.68e-05	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—hematologic cancer	2.62e-05	7.67e-05	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—hematologic cancer	2.62e-05	7.67e-05	CcSEcCtD
Letrozole—Infection—Methotrexate—hematologic cancer	2.61e-05	7.62e-05	CcSEcCtD
Letrozole—Nausea—Etoposide—hematologic cancer	2.6e-05	7.61e-05	CcSEcCtD
Letrozole—Hypertension—Epirubicin—hematologic cancer	2.6e-05	7.6e-05	CcSEcCtD
Letrozole—Feeling abnormal—Prednisone—hematologic cancer	2.59e-05	7.56e-05	CcSEcCtD
Letrozole—Asthenia—Betamethasone—hematologic cancer	2.59e-05	7.56e-05	CcSEcCtD
Letrozole—Asthenia—Dexamethasone—hematologic cancer	2.59e-05	7.56e-05	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—hematologic cancer	2.58e-05	7.55e-05	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—hematologic cancer	2.57e-05	7.52e-05	CcSEcCtD
Letrozole—Gastrointestinal pain—Prednisone—hematologic cancer	2.57e-05	7.51e-05	CcSEcCtD
Letrozole—Nausea—Prednisolone—hematologic cancer	2.57e-05	7.5e-05	CcSEcCtD
Letrozole—Myalgia—Epirubicin—hematologic cancer	2.56e-05	7.49e-05	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—hematologic cancer	2.56e-05	7.49e-05	CcSEcCtD
Letrozole—Chest pain—Epirubicin—hematologic cancer	2.56e-05	7.49e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.56e-05	0.00197	CbGpPWpGaD
Letrozole—Anxiety—Epirubicin—hematologic cancer	2.55e-05	7.46e-05	CcSEcCtD
Letrozole—Pruritus—Dexamethasone—hematologic cancer	2.55e-05	7.46e-05	CcSEcCtD
Letrozole—Pruritus—Betamethasone—hematologic cancer	2.55e-05	7.46e-05	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—hematologic cancer	2.55e-05	7.45e-05	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.54e-05	7.44e-05	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—hematologic cancer	2.54e-05	7.42e-05	CcSEcCtD
Letrozole—Discomfort—Epirubicin—hematologic cancer	2.53e-05	7.4e-05	CcSEcCtD
Letrozole—Vomiting—Triamcinolone—hematologic cancer	2.53e-05	7.39e-05	CcSEcCtD
Letrozole—Malaise—Doxorubicin—hematologic cancer	2.51e-05	7.34e-05	CcSEcCtD
Letrozole—Rash—Triamcinolone—hematologic cancer	2.51e-05	7.33e-05	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—hematologic cancer	2.51e-05	7.32e-05	CcSEcCtD
Letrozole—Dermatitis—Triamcinolone—hematologic cancer	2.5e-05	7.32e-05	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—hematologic cancer	2.5e-05	7.31e-05	CcSEcCtD
Letrozole—Anorexia—Methotrexate—hematologic cancer	2.5e-05	7.31e-05	CcSEcCtD
Letrozole—Urticaria—Prednisone—hematologic cancer	2.49e-05	7.29e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.49e-05	0.00192	CbGpPWpGaD
Letrozole—Leukopenia—Doxorubicin—hematologic cancer	2.49e-05	7.29e-05	CcSEcCtD
Letrozole—Headache—Triamcinolone—hematologic cancer	2.49e-05	7.28e-05	CcSEcCtD
Letrozole—Body temperature increased—Prednisone—hematologic cancer	2.48e-05	7.26e-05	CcSEcCtD
Letrozole—Abdominal pain—Prednisone—hematologic cancer	2.48e-05	7.26e-05	CcSEcCtD
Letrozole—Diarrhoea—Betamethasone—hematologic cancer	2.47e-05	7.21e-05	CcSEcCtD
Letrozole—Diarrhoea—Dexamethasone—hematologic cancer	2.47e-05	7.21e-05	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—hematologic cancer	2.46e-05	7.19e-05	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—hematologic cancer	2.46e-05	7.18e-05	CcSEcCtD
Letrozole—Oedema—Epirubicin—hematologic cancer	2.46e-05	7.18e-05	CcSEcCtD
Letrozole—Infection—Epirubicin—hematologic cancer	2.44e-05	7.13e-05	CcSEcCtD
Letrozole—Cough—Doxorubicin—hematologic cancer	2.43e-05	7.1e-05	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—hematologic cancer	2.41e-05	7.04e-05	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—hematologic cancer	2.4e-05	7.03e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—B3GAT1—hematologic cancer	2.4e-05	0.00185	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ASNS—hematologic cancer	2.4e-05	0.00185	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—DCK—hematologic cancer	2.4e-05	0.00185	CbGpPWpGaD
Letrozole—Tachycardia—Epirubicin—hematologic cancer	2.4e-05	7.01e-05	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.39e-05	6.99e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—PHYH—hematologic cancer	2.39e-05	0.00184	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—FTCD—hematologic cancer	2.39e-05	0.00184	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GMPS—hematologic cancer	2.39e-05	0.00184	CbGpPWpGaD
Letrozole—Skin disorder—Epirubicin—hematologic cancer	2.39e-05	6.97e-05	CcSEcCtD
Letrozole—Dizziness—Dexamethasone—hematologic cancer	2.38e-05	6.97e-05	CcSEcCtD
Letrozole—Dizziness—Betamethasone—hematologic cancer	2.38e-05	6.97e-05	CcSEcCtD
Letrozole—Hyperhidrosis—Epirubicin—hematologic cancer	2.37e-05	6.94e-05	CcSEcCtD
Letrozole—Insomnia—Methotrexate—hematologic cancer	2.37e-05	6.94e-05	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—hematologic cancer	2.37e-05	6.93e-05	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—hematologic cancer	2.37e-05	6.93e-05	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—hematologic cancer	2.37e-05	6.93e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	2.37e-05	0.00183	CbGpPWpGaD
Letrozole—Anxiety—Doxorubicin—hematologic cancer	2.36e-05	6.91e-05	CcSEcCtD
Letrozole—Nausea—Triamcinolone—hematologic cancer	2.36e-05	6.9e-05	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—hematologic cancer	2.36e-05	6.89e-05	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.35e-05	6.88e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.34e-05	0.00181	CbGpPWpGaD
Letrozole—Discomfort—Doxorubicin—hematologic cancer	2.34e-05	6.85e-05	CcSEcCtD
Letrozole—Anorexia—Epirubicin—hematologic cancer	2.34e-05	6.84e-05	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—hematologic cancer	2.34e-05	6.84e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	2.33e-05	0.0018	CbGpPWpGaD
Letrozole—Somnolence—Methotrexate—hematologic cancer	2.33e-05	6.82e-05	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—hematologic cancer	2.32e-05	6.78e-05	CcSEcCtD
Letrozole—Dyspepsia—Methotrexate—hematologic cancer	2.31e-05	6.75e-05	CcSEcCtD
Letrozole—Vomiting—Dexamethasone—hematologic cancer	2.29e-05	6.7e-05	CcSEcCtD
Letrozole—Vomiting—Betamethasone—hematologic cancer	2.29e-05	6.7e-05	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—hematologic cancer	2.28e-05	6.67e-05	CcSEcCtD
Letrozole—Rash—Betamethasone—hematologic cancer	2.27e-05	6.65e-05	CcSEcCtD
Letrozole—Rash—Dexamethasone—hematologic cancer	2.27e-05	6.65e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—HDC—hematologic cancer	2.27e-05	0.00175	CbGpPWpGaD
Letrozole—Anaphylactic shock—Doxorubicin—hematologic cancer	2.27e-05	6.64e-05	CcSEcCtD
Letrozole—Oedema—Doxorubicin—hematologic cancer	2.27e-05	6.64e-05	CcSEcCtD
Letrozole—Dermatitis—Dexamethasone—hematologic cancer	2.27e-05	6.64e-05	CcSEcCtD
Letrozole—Dermatitis—Betamethasone—hematologic cancer	2.27e-05	6.64e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	2.27e-05	0.00175	CbGpPWpGaD
Letrozole—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.27e-05	6.62e-05	CcSEcCtD
Letrozole—Fatigue—Methotrexate—hematologic cancer	2.26e-05	6.61e-05	CcSEcCtD
Letrozole—Headache—Dexamethasone—hematologic cancer	2.26e-05	6.6e-05	CcSEcCtD
Letrozole—Headache—Betamethasone—hematologic cancer	2.26e-05	6.6e-05	CcSEcCtD
Letrozole—Infection—Doxorubicin—hematologic cancer	2.26e-05	6.6e-05	CcSEcCtD
Letrozole—Asthenia—Prednisone—hematologic cancer	2.25e-05	6.59e-05	CcSEcCtD
Letrozole—Pain—Methotrexate—hematologic cancer	2.24e-05	6.56e-05	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.24e-05	6.54e-05	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—hematologic cancer	2.23e-05	6.51e-05	CcSEcCtD
Letrozole—Pruritus—Prednisone—hematologic cancer	2.22e-05	6.49e-05	CcSEcCtD
Letrozole—Insomnia—Epirubicin—hematologic cancer	2.22e-05	6.49e-05	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—hematologic cancer	2.22e-05	6.48e-05	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—hematologic cancer	2.21e-05	6.45e-05	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—hematologic cancer	2.21e-05	6.45e-05	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—hematologic cancer	2.2e-05	6.42e-05	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—hematologic cancer	2.19e-05	6.4e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—SMPD3—hematologic cancer	2.18e-05	0.00168	CbGpPWpGaD
Letrozole—Somnolence—Epirubicin—hematologic cancer	2.18e-05	6.38e-05	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—hematologic cancer	2.17e-05	6.33e-05	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—hematologic cancer	2.16e-05	6.32e-05	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—hematologic cancer	2.16e-05	6.32e-05	CcSEcCtD
Letrozole—Diarrhoea—Prednisone—hematologic cancer	2.15e-05	6.28e-05	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—hematologic cancer	2.15e-05	6.27e-05	CcSEcCtD
Letrozole—Nausea—Betamethasone—hematologic cancer	2.14e-05	6.26e-05	CcSEcCtD
Letrozole—Nausea—Dexamethasone—hematologic cancer	2.14e-05	6.26e-05	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—hematologic cancer	2.14e-05	6.24e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	2.13e-05	0.00164	CbGpPWpGaD
Letrozole—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.12e-05	6.2e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.12e-05	0.00163	CbGpPWpGaD
Letrozole—Fatigue—Epirubicin—hematologic cancer	2.12e-05	6.19e-05	CcSEcCtD
Letrozole—Constipation—Epirubicin—hematologic cancer	2.1e-05	6.14e-05	CcSEcCtD
Letrozole—Pain—Epirubicin—hematologic cancer	2.1e-05	6.14e-05	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	2.1e-05	0.00162	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	2.09e-05	0.00161	CbGpPWpGaD
Letrozole—Urticaria—Methotrexate—hematologic cancer	2.09e-05	6.09e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CDA—hematologic cancer	2.08e-05	0.0016	CbGpPWpGaD
Letrozole—Dizziness—Prednisone—hematologic cancer	2.08e-05	6.07e-05	CcSEcCtD
Letrozole—Abdominal pain—Methotrexate—hematologic cancer	2.07e-05	6.06e-05	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—hematologic cancer	2.07e-05	6.06e-05	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.07e-05	6.05e-05	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—hematologic cancer	2.06e-05	6.01e-05	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—hematologic cancer	2.04e-05	5.97e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	2.03e-05	0.00157	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—JUN—hematologic cancer	2.03e-05	0.00156	CbGpPWpGaD
Letrozole—Dyspnoea—Doxorubicin—hematologic cancer	2.03e-05	5.92e-05	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—hematologic cancer	2.02e-05	5.92e-05	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—hematologic cancer	2.02e-05	5.91e-05	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—hematologic cancer	2.01e-05	5.87e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—PC—hematologic cancer	2e-05	0.00154	CbGpPWpGaD
Letrozole—Dyspepsia—Doxorubicin—hematologic cancer	2e-05	5.85e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	2e-05	0.00154	CbGpPWpGaD
Letrozole—Vomiting—Prednisone—hematologic cancer	2e-05	5.84e-05	CcSEcCtD
Letrozole—Rash—Prednisone—hematologic cancer	1.98e-05	5.79e-05	CcSEcCtD
Letrozole—Dermatitis—Prednisone—hematologic cancer	1.98e-05	5.78e-05	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—hematologic cancer	1.98e-05	5.77e-05	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.97e-05	0.00152	CbGpPWpGaD
Letrozole—Headache—Prednisone—hematologic cancer	1.97e-05	5.75e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	1.96e-05	0.00151	CbGpPWpGaD
Letrozole—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.96e-05	5.74e-05	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—hematologic cancer	1.96e-05	5.73e-05	CcSEcCtD
Letrozole—Urticaria—Epirubicin—hematologic cancer	1.95e-05	5.7e-05	CcSEcCtD
Letrozole—Constipation—Doxorubicin—hematologic cancer	1.94e-05	5.68e-05	CcSEcCtD
Letrozole—Pain—Doxorubicin—hematologic cancer	1.94e-05	5.68e-05	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—hematologic cancer	1.94e-05	5.68e-05	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—hematologic cancer	1.94e-05	5.68e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GBA—hematologic cancer	1.93e-05	0.00149	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC35B2—hematologic cancer	1.93e-05	0.00149	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—B3GAT1—hematologic cancer	1.91e-05	0.00147	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—DCK—hematologic cancer	1.91e-05	0.00147	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ASNS—hematologic cancer	1.91e-05	0.00147	CbGpPWpGaD
Letrozole—Asthenia—Methotrexate—hematologic cancer	1.88e-05	5.5e-05	CcSEcCtD
Letrozole—Feeling abnormal—Doxorubicin—hematologic cancer	1.87e-05	5.47e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—EP300—hematologic cancer	1.87e-05	0.00144	CbGpPWpGaD
Letrozole—Nausea—Prednisone—hematologic cancer	1.87e-05	5.45e-05	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.86e-05	5.43e-05	CcSEcCtD
Letrozole—Pruritus—Methotrexate—hematologic cancer	1.86e-05	5.43e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—HDC—hematologic cancer	1.81e-05	0.00139	CbGpPWpGaD
Letrozole—Urticaria—Doxorubicin—hematologic cancer	1.81e-05	5.28e-05	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—hematologic cancer	1.8e-05	5.25e-05	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—hematologic cancer	1.8e-05	5.25e-05	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—hematologic cancer	1.8e-05	5.25e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	1.77e-05	0.00137	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTAP—hematologic cancer	1.77e-05	0.00136	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.76e-05	0.00136	CbGpPWpGaD
Letrozole—Asthenia—Epirubicin—hematologic cancer	1.76e-05	5.15e-05	CcSEcCtD
Letrozole—Pruritus—Epirubicin—hematologic cancer	1.74e-05	5.08e-05	CcSEcCtD
Letrozole—Dizziness—Methotrexate—hematologic cancer	1.74e-05	5.07e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.73e-05	0.00134	CbGpPWpGaD
Letrozole—Diarrhoea—Epirubicin—hematologic cancer	1.68e-05	4.91e-05	CcSEcCtD
Letrozole—Vomiting—Methotrexate—hematologic cancer	1.67e-05	4.88e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—CDA—hematologic cancer	1.66e-05	0.00128	CbGpPWpGaD
Letrozole—Rash—Methotrexate—hematologic cancer	1.65e-05	4.84e-05	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—hematologic cancer	1.65e-05	4.83e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.65e-05	0.00127	CbGpPWpGaD
Letrozole—Headache—Methotrexate—hematologic cancer	1.64e-05	4.81e-05	CcSEcCtD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—hematologic cancer	1.63e-05	0.00126	CbGpPWpGaD
Letrozole—Asthenia—Doxorubicin—hematologic cancer	1.63e-05	4.77e-05	CcSEcCtD
Letrozole—Dizziness—Epirubicin—hematologic cancer	1.62e-05	4.75e-05	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—hematologic cancer	1.61e-05	4.7e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—PC—hematologic cancer	1.59e-05	0.00123	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—FHL2—hematologic cancer	1.58e-05	0.00121	CbGpPWpGaD
Letrozole—Vomiting—Epirubicin—hematologic cancer	1.56e-05	4.56e-05	CcSEcCtD
Letrozole—Nausea—Methotrexate—hematologic cancer	1.56e-05	4.56e-05	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—hematologic cancer	1.55e-05	4.55e-05	CcSEcCtD
Letrozole—Rash—Epirubicin—hematologic cancer	1.55e-05	4.53e-05	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—hematologic cancer	1.55e-05	4.52e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—AGRN—hematologic cancer	1.55e-05	0.00119	CbGpPWpGaD
Letrozole—Headache—Epirubicin—hematologic cancer	1.54e-05	4.5e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—SLC35B2—hematologic cancer	1.54e-05	0.00119	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GBA—hematologic cancer	1.54e-05	0.00119	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	1.51e-05	0.00116	CbGpPWpGaD
Letrozole—Dizziness—Doxorubicin—hematologic cancer	1.5e-05	4.39e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—IDH2—hematologic cancer	1.46e-05	0.00113	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMMR—hematologic cancer	1.46e-05	0.00113	CbGpPWpGaD
Letrozole—Nausea—Epirubicin—hematologic cancer	1.46e-05	4.26e-05	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—hematologic cancer	1.44e-05	4.22e-05	CcSEcCtD
Letrozole—Rash—Doxorubicin—hematologic cancer	1.43e-05	4.19e-05	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—hematologic cancer	1.43e-05	4.18e-05	CcSEcCtD
Letrozole—Headache—Doxorubicin—hematologic cancer	1.42e-05	4.16e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—MTAP—hematologic cancer	1.41e-05	0.00108	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.38e-05	0.00106	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ARNTL—hematologic cancer	1.38e-05	0.00106	CbGpPWpGaD
Letrozole—Nausea—Doxorubicin—hematologic cancer	1.35e-05	3.95e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—ACP5—hematologic cancer	1.34e-05	0.00103	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CA9—hematologic cancer	1.34e-05	0.00103	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—hematologic cancer	1.34e-05	0.00103	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFB1—hematologic cancer	1.33e-05	0.00103	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOR2—hematologic cancer	1.32e-05	0.00102	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—IDH1—hematologic cancer	1.26e-05	0.000971	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—FHL2—hematologic cancer	1.25e-05	0.000967	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TXN—hematologic cancer	1.25e-05	0.00096	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCC3—hematologic cancer	1.25e-05	0.00096	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTO1—hematologic cancer	1.25e-05	0.00096	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AGRN—hematologic cancer	1.23e-05	0.000948	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SPHK1—hematologic cancer	1.22e-05	0.00094	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—UGT1A1—hematologic cancer	1.17e-05	0.000903	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMMR—hematologic cancer	1.17e-05	0.000899	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—IDH2—hematologic cancer	1.17e-05	0.000899	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.14e-05	0.000881	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CRABP1—hematologic cancer	1.14e-05	0.000878	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC22A1—hematologic cancer	1.14e-05	0.000878	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	1.13e-05	0.000872	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.13e-05	0.000868	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALOX5—hematologic cancer	1.11e-05	0.000856	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ARNTL—hematologic cancer	1.1e-05	0.000845	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NUP98—hematologic cancer	1.08e-05	0.000829	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ACP5—hematologic cancer	1.07e-05	0.000822	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CA9—hematologic cancer	1.07e-05	0.000822	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOR2—hematologic cancer	1.05e-05	0.000811	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.05e-05	0.000809	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ADCY7—hematologic cancer	1.04e-05	0.000805	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOA3—hematologic cancer	1.04e-05	0.000805	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NUP214—hematologic cancer	1.04e-05	0.000799	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.04e-05	0.000798	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.03e-05	0.000791	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTR—hematologic cancer	1.02e-05	0.000783	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCG2—hematologic cancer	1.02e-05	0.000783	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—IDH1—hematologic cancer	1e-05	0.000773	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ENO2—hematologic cancer	9.96e-06	0.000768	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TXN—hematologic cancer	9.91e-06	0.000764	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCC3—hematologic cancer	9.91e-06	0.000764	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTO1—hematologic cancer	9.91e-06	0.000764	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SPHK1—hematologic cancer	9.7e-06	0.000748	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTT1—hematologic cancer	9.66e-06	0.000744	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.51e-06	0.000733	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SDC1—hematologic cancer	9.44e-06	0.000728	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UGT1A1—hematologic cancer	9.32e-06	0.000719	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC22A1—hematologic cancer	9.07e-06	0.000699	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CRABP1—hematologic cancer	9.07e-06	0.000699	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.02e-06	0.000695	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.9e-06	0.000686	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALOX5—hematologic cancer	8.84e-06	0.000681	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PHYH—hematologic cancer	8.75e-06	0.000675	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GMPS—hematologic cancer	8.75e-06	0.000675	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—FTCD—hematologic cancer	8.75e-06	0.000675	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NUP98—hematologic cancer	8.56e-06	0.00066	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.51e-06	0.000656	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ADCY7—hematologic cancer	8.31e-06	0.00064	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA3—hematologic cancer	8.31e-06	0.00064	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NUP214—hematologic cancer	8.25e-06	0.000636	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTR—hematologic cancer	8.08e-06	0.000623	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCG2—hematologic cancer	8.08e-06	0.000623	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CD44—hematologic cancer	8.03e-06	0.000619	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NQO1—hematologic cancer	8.03e-06	0.000619	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SMPD3—hematologic cancer	8.01e-06	0.000617	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ENO2—hematologic cancer	7.93e-06	0.000611	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.86e-06	0.000606	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTT1—hematologic cancer	7.69e-06	0.000593	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYCS—hematologic cancer	7.6e-06	0.000585	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSP90AA1—hematologic cancer	7.55e-06	0.000582	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SDC1—hematologic cancer	7.51e-06	0.000579	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7e-06	0.000539	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—DCK—hematologic cancer	7e-06	0.000539	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ASNS—hematologic cancer	7e-06	0.000539	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.79e-06	0.000524	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTP1—hematologic cancer	6.69e-06	0.000516	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HDC—hematologic cancer	6.63e-06	0.000511	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.48e-06	0.000499	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CD44—hematologic cancer	6.39e-06	0.000492	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NQO1—hematologic cancer	6.39e-06	0.000492	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCB1—hematologic cancer	6.34e-06	0.000488	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—hematologic cancer	6.15e-06	0.000474	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOR1—hematologic cancer	6.15e-06	0.000474	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CDA—hematologic cancer	6.07e-06	0.000468	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYCS—hematologic cancer	6.05e-06	0.000466	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSP90AA1—hematologic cancer	6.01e-06	0.000463	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PC—hematologic cancer	5.84e-06	0.00045	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.64e-06	0.000435	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GBA—hematologic cancer	5.64e-06	0.000435	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTHFR—hematologic cancer	5.44e-06	0.000419	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTP1—hematologic cancer	5.33e-06	0.000411	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTAP—hematologic cancer	5.16e-06	0.000398	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCB1—hematologic cancer	5.04e-06	0.000389	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOR1—hematologic cancer	4.9e-06	0.000377	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—hematologic cancer	4.9e-06	0.000377	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.79e-06	0.000369	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—FHL2—hematologic cancer	4.6e-06	0.000354	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CG—hematologic cancer	4.57e-06	0.000352	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AGRN—hematologic cancer	4.51e-06	0.000348	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTHFR—hematologic cancer	4.33e-06	0.000334	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—IDH2—hematologic cancer	4.28e-06	0.00033	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMMR—hematologic cancer	4.28e-06	0.00033	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CREBBP—hematologic cancer	4.24e-06	0.000326	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.02e-06	0.00031	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CD—hematologic cancer	4.02e-06	0.00031	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—hematologic cancer	3.96e-06	0.000306	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ACP5—hematologic cancer	3.91e-06	0.000301	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CA9—hematologic cancer	3.91e-06	0.000301	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.86e-06	0.000297	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3R1—hematologic cancer	3.79e-06	0.000292	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—IDH1—hematologic cancer	3.68e-06	0.000283	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CG—hematologic cancer	3.64e-06	0.00028	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TXN—hematologic cancer	3.64e-06	0.00028	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.64e-06	0.00028	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.64e-06	0.00028	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.56e-06	0.000274	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CB—hematologic cancer	3.5e-06	0.00027	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.42e-06	0.000263	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.37e-06	0.00026	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.32e-06	0.000256	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.32e-06	0.000256	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.24e-06	0.00025	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CD—hematologic cancer	3.2e-06	0.000246	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—hematologic cancer	3.16e-06	0.000243	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NUP98—hematologic cancer	3.14e-06	0.000242	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.05e-06	0.000235	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.05e-06	0.000235	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NUP214—hematologic cancer	3.02e-06	0.000233	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTEN—hematologic cancer	3.02e-06	0.000233	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.02e-06	0.000233	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.96e-06	0.000228	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTR—hematologic cancer	2.96e-06	0.000228	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ENO2—hematologic cancer	2.91e-06	0.000224	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—EP300—hematologic cancer	2.88e-06	0.000222	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.82e-06	0.000217	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.79e-06	0.000215	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SDC1—hematologic cancer	2.75e-06	0.000212	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTEN—hematologic cancer	2.41e-06	0.000186	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CD44—hematologic cancer	2.34e-06	0.000181	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NQO1—hematologic cancer	2.34e-06	0.000181	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—EP300—hematologic cancer	2.3e-06	0.000177	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYCS—hematologic cancer	2.22e-06	0.000171	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.2e-06	0.00017	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CA—hematologic cancer	2.13e-06	0.000164	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.95e-06	0.000151	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.85e-06	0.000143	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.8e-06	0.000138	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.8e-06	0.000138	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—hematologic cancer	1.74e-06	0.000134	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.7e-06	0.000131	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.59e-06	0.000122	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—hematologic cancer	1.39e-06	0.000107	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.33e-06	0.000103	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.24e-06	9.53e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.17e-06	9.03e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—hematologic cancer	1.16e-06	8.92e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.11e-06	8.53e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.02e-06	7.87e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTEN—hematologic cancer	8.83e-07	6.8e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—EP300—hematologic cancer	8.42e-07	6.49e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.23e-07	4.8e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—hematologic cancer	5.09e-07	3.92e-05	CbGpPWpGaD
